These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 1855226
21. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, Caporaso NE, Fraumeni JF, Rice JM. Cancer Res; 1995 Jun 15; 55(12):2665-72. PubMed ID: 7780983 [Abstract] [Full Text] [Related]
22. No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers. Victor T, Du Toit R, Jordaan AM, Bester AJ, van Helden PD. Cancer Res; 1990 Aug 15; 50(16):4911-4. PubMed ID: 2199031 [Abstract] [Full Text] [Related]
28. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations. Mahdavinia M, Bishehsari F, Verginelli F, Cumashi A, Lattanzio R, Sotoudeh M, Ansari R, Semeraro D, Hormazdi M, Fakheri H, Rakhshani N, De Lellis L, Curia MC, Cama A, Piantelli M, Malekzadeh R, Iacobelli S, Mariani-Costantini R. J Cell Physiol; 2008 Aug 15; 216(2):543-50. PubMed ID: 18330889 [Abstract] [Full Text] [Related]
30. TP53 gene mutation profile in esophageal squamous cell carcinomas. Audrézet MP, Robaszkiewicz M, Mercier B, Nousbaum JB, Bail JP, Hardy E, Volant A, Lozac'h P, Charles JF, Gouéron H. Cancer Res; 1993 Dec 01; 53(23):5745-9. PubMed ID: 8242631 [Abstract] [Full Text] [Related]
31. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP. Cancer Res; 1992 Nov 01; 52(21):6092-7. PubMed ID: 1394236 [Abstract] [Full Text] [Related]
32. p53 mutations in lung cancer following radiation therapy for Hodgkin's disease. De Benedetti VM, Travis LB, Welsh JA, van Leeuwen FE, Stovall M, Clarke EA, Boice JD, Bennett WP. Cancer Epidemiol Biomarkers Prev; 1996 Feb 01; 5(2):93-8. PubMed ID: 8850268 [Abstract] [Full Text] [Related]
35. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M, Ataizi-Celikel C, Düşünceli F, Sönmez O, Gulluoglu BM, Sav A, Ozer A. J Gastrointestin Liver Dis; 2007 Mar 01; 16(1):11-7. PubMed ID: 17410283 [Abstract] [Full Text] [Related]
36. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Chang KW, Sarraj S, Lin SC, Tsai PI, Solt D. Carcinogenesis; 2000 Jul 01; 21(7):1441-51. PubMed ID: 10874024 [Abstract] [Full Text] [Related]
37. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis. Löhr M, Müller P, Mora J, Brinkmann B, Ostwald C, Farré A, Lluis F, Adam U, Stubbe J, Plath F, Nizze H, Hopt UT, Barten M, Capellá G, Liebe S. Gastrointest Endosc; 2001 Jun 01; 53(7):734-43. PubMed ID: 11375580 [Abstract] [Full Text] [Related]
38. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE. Cancer Res; 1999 Aug 01; 59(15):3634-40. PubMed ID: 10446974 [Abstract] [Full Text] [Related]
39. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer. Hensel CH, Xiang RH, Sakaguchi AY, Naylor SL. Oncogene; 1991 Jun 01; 6(6):1067-71. PubMed ID: 1648702 [Abstract] [Full Text] [Related]
40. Frequent association of p53 gene mutation in invasive bladder cancer. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M. Cancer Res; 1992 Mar 15; 52(6):1393-8. PubMed ID: 1540947 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]